AI
AGN

Atom Investors’s Allergan plc AGN Stock Holding History

Atom Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,163
Closed -$1.62M – 516
2020
Q1 		$1.62M Buy
9,163
+8,110
+770% +$1.53M 0.14% 126
2019
Q4 		$201K Sell
1,053
-19,828
-95% -$3.58M 0.02% 225
2019
Q3 		$3.51M Sell
20,881
-133,571
-86% -$21.8M 0.24% 123
2019
Q2 		$25.9M Buy
154,452
+145,585
+1,642% +$20.2M 1.68% 4
2019
Q1 		$1.3M Sell
8,867
-21,169
-70% -$3.07M 0.11% 158
2018
Q4 		$4.01M Buy
+30,036
New +$4.92M 0.4% 57

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Atom Investors's AGN Position: Q2 2020 in Review

Atom Investors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,163 shares — an estimated $1.62M sold.

Atom Investors first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $25.9M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Atom Investors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Atom Investors sold 9,163 Allergan plc shares in Q2 2020, an estimated $1.62M.
  • Atom Investors first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Atom Investors's Allergan plc position peaked at $25.9M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Atom Investors's 13F filing for Q2 2020, filed 14 Aug 2020.